We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Safety and Efficacy Trial of Beclomethasone Dipropionate in Allergic Rhinitis

- Rhinitis, Female, Maleergic, Perennial
- Completed

Study Title: Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Female, Maleergic Rhinitis

Teva Identifier: BDP-AR-303

ClinicalTrials.gov Identifier: NCT00988247

Study Status: Completed

Trial Condition(s): Rhinitis, Female, Maleergic, Perennial

Interventions: Drug: Beclomethasone dipropionate | Drug: Placebo Nasal Aerosol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: 10/01/2009 - 02/01/2011

Phase: Phase 3

Study Type

Interventional